Gamma-glutamyl transferase: A potential biomarker for pancreas steatosis in patients with concurrent obesity, insulin resistance and metabolic dysfunction-associated steatotic liver disease.

MLA

Chiyanika, Chileka, et al. “Gamma-Glutamyl Transferase: A Potential Biomarker for Pancreas Steatosis in Patients with Concurrent Obesity, Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease.” Clinical Obesity, vol. 15, no. 1, Feb. 2025, p. e12712. EBSCOhost, https://doi.org/10.1111/cob.12712.

APA

Chiyanika, C., Shumbayawonda, E., Pansini, M., Liu, K. H., Yip, T. C.-F., Wong, V. W.-S., & Chu, W. C. W. (2025). Gamma-glutamyl transferase: A potential biomarker for pancreas steatosis in patients with concurrent obesity, insulin resistance and metabolic dysfunction-associated steatotic liver disease. Clinical Obesity, 15(1), e12712. https://doi.org/10.1111/cob.12712

Chicago

Chiyanika, Chileka, Elizabeth Shumbayawonda, Michele Pansini, Kin Hung Liu, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, and Winnie Chiu Wing Chu. 2025. “Gamma-Glutamyl Transferase: A Potential Biomarker for Pancreas Steatosis in Patients with Concurrent Obesity, Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease.” Clinical Obesity 15 (1): e12712. doi:10.1111/cob.12712.